EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma

Qingqing Luo iD, Lei Xiao iD, Ganlu Deng iD, Tan Deng, Wenchao Zhao iD, Rensheng Wang iD, Xueying Hu iD

Human Mutation · 2026-01 · 2026 (1)

DOI: 10.1155/humu/2654435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, online erschienen am 29.04.2026. Verfasst von Qingqing Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology & Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, The First Affiliated Hospit…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cell Proliferation, Liver Neoplasms, Nuclear Factor 90 Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is a major type of primary liver cancer. Previous studies have reported that interleukin enhancer–binding factor 3 (ILF3) is involved in the regulation of multiple cancers. This study investigated the molecular mechanisms whereby ILF3 promotes HCC progression.

Methods

ILF3 expression levels were determined through immunohistochemistry (IHC) and Western blot (WB) analyses. The biological functions of ILF3 in HCC were evaluated using both in vitro assays and in vivo animal models. Co‐immunoprecipitation (Co‐IP) was carried out to identify HMGCL as a binding partner of ILF3. To clarify the potential molecular pathways underlying ILF3‐mediated regulation of HCC malignant behaviors, protein stability assays and in vitro ubiquitination experiments were performed.

Results

ILF3 was significantly upregulated in HCC. The patients with high expression of ILF3 showed poor prognosis in our cohort. ILF3 knockdown inhibited the proliferation and metastasis of HCC cells both in vitro and in vivo in this study. Mechanistically, ILF3 was found to be bound to HMGCL and to accelerate its protein degradation. Additionally, we found that ILF3 promotes HCC cell proliferation and metastasis through HMGCL. Overexpression of HMGCL in ILF3‐upregulated HCC cells could significantly reverse the proliferation and invasion role of ILF3 on HCC cells. Moreover, USP38 was identified as a deubiquitinating enzyme that participates in promoting the stability of HMGCL. ILF3 disrupted the interaction between USP38 and HMGCL, thereby enhancing HMGCL ubiquitination and accelerating its degradation.

Conclusion

ILF3 promotes the proliferation and metastasis of HCC by enhancing the ubiquitination of HMGCL by interfering with the interaction between the deubiquitinase USP38 and HMGCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCell ProliferationLiver NeoplasmsNuclear Factor 90 ProteinsOxo-Acid-LyasesUbiquitin-Specific ProteasesNeoplasm MetastasisHumansMaleFemaleAnimalsMiceMice, NudeDisease ProgressionEpithelial-Mesenchymal TransitionCell Line, TumorProtein BindingGene Expression Regulation, NeoplasticProteasome Endopeptidase Complex

Stichwörter der Autor:innen

HCCHMGCLILF3USP38deubiquitinase

Substanzen

Nuclear Factor 90 ProteinsILF3 protein, human3-hydroxy-3-methylglutaryl-coenzyme A lyaseOxo-Acid-LyasesUSP38 protein, humanUbiquitin-Specific ProteasesProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Radiation Oncology & Guangxi Key Laboratory of Enhanced Recovery After Surgery for Gastrointestinal Cancer, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China, gxmu.edu.cn.
  • Department of Oncology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan Province, China, hunnu.edu.cn.
  • Department of Colorectal Surgery, Hunan Cancer Hospital/Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan Province, China, csu.edu.cn.
  • Department of Oncology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China, gxmu.edu.cn.

ORCID-Profile: Qingqing Luo, Lei Xiao, Ganlu Deng, Wenchao Zhao, Rensheng Wang, Xueying Hu

Förderung

  • Natural Science Foundation of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Luo, Q., Xiao, L., Deng, G., Deng, T., Zhao, W., Wang, R., & Hu, X. (2026). ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma. Human Mutation, 2026(1). https://doi.org/10.1155/humu/2654435

Vancouver

Luo Q, Xiao L, Deng G, Deng T, Zhao W, Wang R, et al. ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma. Human Mutation. 2026;2026(1). doi:10.1155/humu/2654435

BibTeX
@article{Luo2026,
  author = {Luo, Qingqing and Xiao, Lei and Deng, Ganlu and Deng, Tan and Zhao, Wenchao and Wang, Rensheng and Hu, Xueying},
  title = {ILF3 Regulates Cell Proliferation and Metastasis by Competitively Antagonizing the Interaction Between HMGCL and USP38 in Hepatocellular Carcinoma},
  journal = {Human Mutation},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/humu/2654435}
}
Kostenlos starten →